Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

Also called NCT07547306

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07547306
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07547306. Randomized; no masking; primary purpose treatment. Start 2026-05 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator
Acronym
BRIDGE-HF
Condition
Heart Failure and Reduced Ejection Fraction
Intervention (Device)
BBAP on
Intervention (Device)
BBAP off
Intervention (Drug)
RAAP
Lead sponsor
Seoul National University Hospital (class: other)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct07547306
Content hash
db7e015e9ce0410412cfa8694b7eed7d006d55d7d5775b837dc0739788b00e2a